What Nufactor does

Nufactor is a US specialty pharmacy subsidiary of FFF Enterprises, Inc., founded in 1995 and headquartered in Temecula, California. The company dispenses home infusion and specialty injectable therapies — primarily immune globulin (IVIG and SCIG), complement and TNF inhibitors (eculizumab, golimumab, guselkumab, infliximab), rituximab, tetrabenazine, plasminogen, and bleeding disorder products — for patients with primary and secondary immunodeficiencies, autoimmune and neuroimmunologic disorders, and rare diseases. Operations are anchored by three licensed pharmacy locations (Temecula CA, Kernersville NC, Flower Mound TX) and supported by a nationwide contracted skilled nursing network for in-home administration, with patient and provider onboarding handled via PDF referral forms and a dedicated contact center.

The Nufactor Service Model wraps each dispense with a dedicated Patient Care Coordinator, prior authorization and reimbursement support, supply management, anaphylaxis-kit provisioning, and 24/7 clinical pharmacist access. Clinical staff hold specialized credentials including IgCN, IgCP, CSP, and OCN, and the company maintains Joint Commission accreditation alongside URAC Specialty Pharmacy and URAC Rare Disease Pharmacy Center of Excellence designations. The Infusion Nursing Notes blog serves as a CE-eligible educational platform for the home infusion nursing community, and a Site of Care Savings Program targets payers on the cost differential between home and facility-administered infusion.

Revenue is generated principally through specialty pharmacy dispensing reimbursed via patient insurance, with in-house reimbursement specialists handling prior authorization and payer billing. Therapy-specific clinical coordination services — PCC case management, in-home skilled nursing arrangements, and clinical pharmacist/nurse educator consultations — are bundled into the dispense. Go-to-market is enterprise field sales–oriented, targeting prescribers, payers, and patient referrals across the United States; pricing is not publicly disclosed.

Name

Nufactor

Legal name

Nufactor, Inc.

Website

https://nufactor.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

Nufactor is a US specialty pharmacy subsidiary of FFF Enterprises that dispenses home infusion and specialty injectable therapies — including IVIG, SCIG, eculizumab, infliximab, and rituximab — serving patients with immunodeficiencies, autoimmune disorders, and rare diseases nationwide.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy / Home Infusion Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Health Care and Social Assistance (62)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Specialty pharmacy services
• Home infusion therapy
• Immune globulin therapy
• Specialty biologics dispensing
• Patient care coordination

Headquarters

HQ city

Temecula

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Specialty pharmacy dispensing & home infusion services: Revenue generated from dispensing specialty and infusion medications (IVIG, SCIG, eculizumab, golimumab, guselkumab, infliximab, rituximab, tetrabenazine, plasminogen, YCANTH, VTAMA, bleeding disorder products) for home delivery, with reimbursement billed directly to patient insurance. Reimbursement specialists handle prior authorization and insurance billing on behalf of patients; pharmacy supplies, equipment, and clinical/nursing coordination bundled around each dispense.
2. Therapy-specific clinical and nursing service fees: Revenue from clinical care coordination services per therapy line, including Patient Care Coordinator case management, in-home skilled nursing visits arranged through partner nursing agencies, and clinical pharmacist/nurse educator consultations; priced as part of the specialty pharmacy dispense.

Go-to-market motion1 record

Core offering

Nufactor is a specialty pharmacy and home infusion provider that dispenses and coordinates specialty injectable and biologic therapies — primarily immune globulin (IVIG/SCIG), TNF and complement inhibitors, anti-CD20 monoclonal antibodies, tetrabenazine, plasminogen, YCANTH, VTAMA, and bleeding disorder products — for delivery and administration in patients' homes. Each dispense is wrapped in a dedicated Patient Care Coordinator model that handles scheduling, supply management, prior authorization, reimbursement, and nationwide skilled nursing coordination, with three licensed pharmacy locations in CA, NC, and TX serving patients across the United States.

Product overview

Nufactor operates as a specialty pharmacy subsidiary of FFF Enterprises, providing a portfolio of home infusion and specialty injectable therapies (including Immune Globulin Intravenous (IVIG), Subcutaneous Immune Globulin (SCIG), Eculizumab (Soliris®), Golimumab (Simponi®, Simponi Aria®), Guselkumab (Tremfya®), Infliximab (Remicade®, Inflectra®, Renflexis®), Rituximab (Rituxan®), Tetrabenazine, YCANTH® (cantharidin 0.7%), Plasminogen (Ryplazim®), VTAMA®, and bleeding disorder products) under a unified Nufactor Service Model. The platform-plus-services architecture centers on a core specialty pharmacy dispensing operation across three U.S. pharmacy locations (Temecula, CA; Kernersville, NC; Flower Mound, TX), supported by wraparound services including Patient Care Coordination, Reimbursement and Insurance Support, a Site of Care Savings Program for payers, nationwide Home Infusion Nursing, an Infusion Nursing Notes educational blog, advocacy/Ask Nufactor resources, and dedicated Patient (Become a Nufactor Patient) and Provider (Refer Your Patient) onboarding workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• Immune Globulin, Intravenous (IVIG) Intravenous immune globulin therapy for the treatment of primary and secondary immunodeficiencies, autoimmune/inflammatory conditions, neuroimmunologic disorders, and infection-related sequelae, delivered via home infusion under Nufactor's specialty pharmacy service model.
• Immune Globulin, Subcutaneous (SCIG) Subcutaneous immune globulin therapy (including facilitated SCIG such as HyQvia) administered under the skin for chronic conditions, providing more stable steady-state Ig levels and reduced systemic adverse drug reactions compared to IVIG.
• Eculizumab (Soliris®) Home infusion of the complement inhibitor eculizumab (Soliris®) for patients with rare hematologic and renal conditions.
• Golimumab (Simponi®, Simponi Aria®) Home infusion of the TNF inhibitor golimumab for inflammatory autoimmune conditions including rheumatologic and gastrointestinal diseases.
• Guselkumab (Tremfya®) Home infusion of the IL-23 inhibitor guselkumab (Tremfya®) for plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease.
• Infliximab (Remicade®, Inflectra®) Home infusion of the TNF-alpha inhibitor infliximab and biosimilars (Remicade®, Inflectra®, Renflexis®) for autoimmune conditions such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, and other immune-mediated disorders.
• Rituximab (Rituxan®) Home infusion of the anti-CD20 monoclonal antibody rituximab and biosimilars for autoimmune conditions and certain hematologic disorders.
• Tetrabenazine Home delivery and management of tetrabenazine for the treatment of chorea associated with Huntington's disease.
• YCANTH® (cantharidin) Topical Solution 0.7% Specialty distribution of YCANTH® (cantharidin) topical solution 0.7%, a healthcare professional-administered treatment for molluscum contagiosum, supported by a dedicated contact line (800-315-0155).
• Plasminogen (Ryplazim®) Home infusion of plasminogen (Ryplazim®) for patients with plasminogen deficiency, supported by a dedicated referral form.
• VTAMA® (tapinarof) Distribution of VTAMA® (tapinarof) cream, a topical prescription therapy, supported by a dedicated referral form.
• Bleeding Disorder Therapies Specialty home infusion of factor and non-factor therapies for patients with hemophilia, von Willebrand disease, and other bleeding disorders.
• Home Infusion Nursing Service Nationwide coordination of qualified skilled nursing agencies to administer specialty infusion therapies in the patient's home, including anaphylaxis kit provisioning, 24/7 pharmacist access, and supply management.
• Patient Care Coordination Dedicated Patient Care Coordinator (PCC) assigned to each patient to serve as the main point of contact throughout service, handling scheduling, refills, supply management, and prior authorization.
• Reimbursement and Insurance Support Insurance specialists and reimbursement staff who obtain prior authorization, manage payer relationships, handle appeals, and bill insurance on the patient's behalf, supported by a Healthcare Insurance Companies Directory resource.
• Site of Care Savings Program Payer-facing program highlighting cost savings when specialty infusion therapies are administered in the home versus hospital or facility sites of care.

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Amerita: Amerita is a national specialty and home infusion pharmacy focused on IVIG and complex biologics, closely comparable to Nufactor in therapy portfolio, clinical service model, and home-based care delivery.
• Option Care Health: Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S., directly comparable to Nufactor in therapy mix, home infusion delivery, and specialty pharmacy services.
• Soleo Health: Soleo Health is a national specialty pharmacy and home infusion provider focused on IVIG/SCIG and complex specialty biologics, overlapping directly with Nufactor's core therapy portfolio and home infusion service model.
• Diplomat Pharmacy (Optum Specialty): Diplomat Pharmacy, founded as a specialty pharmacy serving patients with chronic and rare conditions, was a high-touch specialty pharmacy peer; its business has been integrated into Optum Specialty, providing context on the consolidation landscape Nufactor operates in.
• BioPlus Specialty Pharmacy: BioPlus (now part of CarelonRx) is a specialty pharmacy focused on complex chronic conditions including immunology and rare disease therapies, with a similar PCC-style care model and home-delivered specialty drug mix to Nufactor.

Broad incumbents

• Accredo (Express Scripts): Accredo is one of the largest specialty pharmacies in the U.S., offering a broad portfolio including IVIG and specialty biologics — overlapping with Nufactor's therapy mix but operating at vastly greater scale with national payer integration.
• CVS Specialty / Coram: CVS Specialty and its Coram home infusion unit provide specialty pharmacy and home infusion services across immunology and rare disease, representing a scaled incumbent competitor with deep payer and PBM relationships.
• Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy provides specialty and home infusion services across immunology and rare disease through a national footprint, representing a scaled incumbent with overlapping therapy categories to Nufactor.
• Optum Specialty Pharmacy (BriovaRx): Optum Specialty Pharmacy (formerly BriovaRx) is a leading PBM-owned specialty pharmacy offering a broad specialty biologic portfolio with national home delivery, directly comparable in therapy categories to Nufactor.

Emerging players

• InfuSystem Holdings: InfuSystem provides ambulatory infusion pumps and related services to specialty pharmacies and home infusion providers, representing an adjacent ecosystem enabler rather than a direct dispense competitor to Nufactor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nufactor